Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Is Insulin Omission a Surrogate Marker of Eating Disorders and Severity of Diabetes-related Distress: an Exploratory Study.

NCT05476861 is registered in ClinicalTrials.gov with Laval University as lead sponsor.

NCT NCT05476861
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05476861 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Is Insulin Omission a Surrogate Marker of Eating Disorders and Severity of Diabetes-related Distress: an Exploratory Study.
Lead sponsor
Laval University
Phase
Observational
Overall status
Completed
Start date
November 1, 2022
Completion date
May 10, 2023
Enrollment
751 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes